Recombinant retroviral vectors are attractive for in vivo gene transfe
r into the liver because they integrate into the host-cell genome, res
ulting in permanent gene expression. Gene-transfer efficiency can be i
mproved by increasing the number of retroviral particles delivered to
hepatocytes, For this purpose, we report a mouse model for continuous
infusion into the portal circulation permitting large-volume vector ad
ministration, which will allow marked increase in gene-transfer effici
ency. Continuous saline infusion was evaluated, using various paramete
rs, and an infusion rate of 6 ml/24 h was found safe and well tolerate
d for at least 2 weeks. No significant changes in liver and kidney fun
ction and electrolyte balance were observed during the infusion. In ad
dition to providing a valuable method for in vivo hepatic gene therapy
, this model has a number of other potential applications, including m
ouse studies of hepatic tumor therapy, pharmacology, toxicology, and l
iver biology.